iShares US Pharmaceuticals ETF
IHE
IHE
103 hedge funds and large institutions have $358M invested in iShares US Pharmaceuticals ETF in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
24% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 38
Holders
103
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$32.3M | |
| 2 | +$10.5M | |
| 3 | +$6.42M | |
| 4 |
Morgan Stanley
New York
|
+$4.31M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.96M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$14.9M | |
| 3 | -$7.45M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3.78M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$3.49M |